Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Prevalence
50%
Hepatitis C Virus
38%
Infection
36%
Diseases
35%
Hepatitis C
31%
Elimination
25%
Antiviral Drug
21%
Hepatitis B Virus
21%
Antivirus Agent
19%
Virus Hepatitis
18%
Drug Resistance
18%
Hepatitis B
16%
Integrase
13%
Lamivudine
11%
Chemokine Receptor
10%
Human Immunodeficiency Virus Infection
9%
Human Immunodeficiency Virus 1
9%
Chronic Hepatitis C
9%
Nucleocapsid Protein
9%
Nucleic Acid
9%
Anti-Human Immunodeficiency Virus
9%
Lopinavir Plus Ritonavir
8%
Viremia
7%
Antiviral Therapy
7%
Antiviral Activity
7%
Zidovudine
6%
Raltegravir
6%
IC50
5%
Beta Chemokine
5%
Efavirenz
5%
Cassia
5%
Nonnucleoside Reverse Transcriptase Inhibitor
5%
Oleanolic Acid
5%
Taxifolin
5%
Palmitic Acid
5%
HIV Drug Resistance
5%
Receptor
5%
Multidrug Resistance
5%
Immunology and Microbiology
Human Immunodeficiency Virus 1
86%
Viral Load
31%
Prevalence
24%
Human Immunodeficiency Virus
23%
T-Helper Cell
20%
Blood Plasma
19%
Hepatitis C Virus
18%
Omicron Coronavirus Variant
15%
Virus
14%
Dynamics
14%
Breakthrough Infection
14%
Natural Killer Cell
13%
Hepatitis C
12%
Cell Surface
11%
Cladistics
11%
Drug Resistance
11%
CXCR4
11%
Neutralization
10%
T Cell
10%
Disease Burden
10%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Humanized Mouse
9%
Peptides
9%
Chemokine Receptor
9%
Human Immunodeficiency Virus Infection
9%
Human Immunodeficiency Virus Type 1 Subtype C
9%
Virus Infectivity
9%
Hepatitis B
9%
Hepatitis B Virus
8%
CD4
7%
Neutralizing Antibody
7%
Integrase
7%
Molecular Epidemiology
6%
HBsAg
6%
Hepatitis B Antigen
6%
Dendritic Cell
6%
Human Immunodeficiency Virus Type 1 Subtype B
6%
CD4 Lymphocyte Count
6%
Reverse Transcriptase
6%
Protein Expression
5%
Agonist
5%
Amino Terminal Sequence
5%
CCR5
5%
Viremia
5%
Phage Display
5%
Nitric Oxide Synthase
5%
Molecular Clock
5%
Cell Differentiation
5%
Tumor Cell
5%
Virus Type
5%
Keyphrases
Europe
18%
People Who Inject Drugs
12%
EMCDDA
10%
AIDS/HIV
10%
Plasma Viral Load
9%
Protein Complex
9%
Transmission Dynamics
9%
Functional Components
9%
Public Health Risk
6%
Infectious Diseases
6%
WHO European Region
6%
Drug Dependence
6%
Expert Networks
6%
European Economic Area
5%
Subendemics
5%